Citius Pharmaceuticals Inc vs eBay Inc — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $18.73M), while eBay Inc trades at $106.12 (market cap $47.93B). The key difference: eBay Inc is far larger — about 2559× Citius Pharmaceuticals Inc's market cap, and eBay Inc pays a 1.15% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | EBAY | |
|---|---|---|
Market Cap | $18.73M | $47.93B |
Sector | Health | Consumer Cyclical |
52-Week High | $1.82 | $118.96 |
52-Week Low | $0.48 | $79.41 |
Enterprise Value | $14.95M | $51.75B |
Volume | — | 5,186,418 |
Dividend Yield | — | 1.15% |
Signals from Pluang's Aura AI — not financial advice
CTXR is trading at $0.68, up 6.28% today, with a bullish technical signal from moving averages. The company shows strong commercial momentum with LYMPHIR cancer treatment revenue reaching $5.6 million in H1 2026, though it remains unprofitable with a -823% net margin. Analyst consensus is strongly bullish with 83% buy ratings.
The outlook depends on LYMPHIR's commercial success offsetting deep losses. Near-term catalysts include expanded market access and combination therapy data, but high cash burn and execution risks require monitoring. The stock offers speculative growth potential in oncology but carries significant financial risk.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →